IMBRUVICA
Capsule, hard, 140mg
RxActive license
Active substance (INN)
ibrutinib
Pharmaceutical form
Pharmaceutical formCapsule, hard
Strength140mg
PackagingUkupno 90 kapsula, tvrdih u boci plastičnoj u kartonskoj kutiji
ManufacturerJanssen Pharmaceutica N.V., Belgium
Therapeutic groupAntineoplastic and immunomodulating agents (L01EL01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJanuary 11, 2016
Source: CInMED register